Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Immunosuppression

In: Tumour Site Concordance and Mechanisms of Carcinogenesis. Lyon (FR): International Agency for Research on Cancer; 2019. Chapter 16.
Review

Immunosuppression

Jerry M. Rice.
No abstract available

PubMed Disclaimer

References

    1. Biggar RJ, Henle G, Böcker J, Lennette ET, Fleisher G, Henle W (1978). Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion. Int J Cancer. 22(3):244–50. 10.1002/ijc.2910220305 - DOI - PubMed
    1. Bouvard V, Baan RA, Grosse Y, Lauby-Secretan B, El Ghissassi F, Benbrahim-Tallaa L, et al. ; WHO International Agency for Research on Cancer Monograph Working Group (2012). Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol. 13(4):339–40. 10.1016/S1470-2045(12)70125-0 - DOI - PubMed
    1. Chelimo K, Ofulla AV, Narum DL, Kazura JW, Lanar DE, John CC (2005). Antibodies to Plasmodium falciparum antigens vary by age and antigen in children in a malaria-holoendemic area of Kenya. Pediatr Infect Dis J. 24(8):680–4. 10.1097/01.inf.0000172151.28851.fd - DOI - PubMed
    1. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. ; Swiss HIV Cohort (2005). Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 97(6):425–32. 10.1093/jnci/dji072 - DOI - PubMed
    1. Cunnington AJ, Riley EM (2010). Suppression of vaccine responses by malaria: insignificant or overlooked? Expert Rev Vaccines. 9(4):409–29. 10.1586/erv.10.16 - DOI - PubMed